DBAC DBAC DBAC DBAC
  • Dansk BørneAstma Center
    • Om DBAC
    • Beliggenhed
    • Fonde og donationer
    • Persondatapolitik
  • Børneastma
    • Generelt om astma hos børn
    • Asthma hos små børn
    • Astma hos større børn
    • Generel astma behandling
    • Astmabehandling småbørn
    • Astmabehandling større børn
    • Undersøgelser
    • Gode råd
    • Litteratur til forældre
  • Allergi og eksem
    • Generelt om allergi
    • Mælkeallergi
    • Generelt om eksem
  • Kliniske studier
    • COPSAC 2010 (ABC)
    • COPSAC-Severe
    • COPSAC Acute (Antibiotika)
  • Video

Telegiz: Fish Oil During Pregnancy Cuts Down Asthma Risk in Babies

    Home News Telegiz: Fish Oil During Pregnancy Cuts Down Asthma Risk in Babies
    NextPrevious

    Telegiz: Fish Oil During Pregnancy Cuts Down Asthma Risk in Babies

    By Dansk Børne Astma Center | News, PUFA | Comments are Closed | 2 januar, 2017 | 0

    By Dane Lorica

    Blood samples were taken before and after consumption of supplements. According to the results, women who received low levels of fish oil’s primary ingredients, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), lowered their children’s rate of wheezing and asthma to 17.5 from 34.1 percent. However, it was observed that allergies from egg products, milk, and severe asthma cannot be reduced by fish oil intake.

    Dr. Hans Bisgaard advised that besides taking supplements, women should “really need to be very fond of fish to get sufficient amounts” of fish oil benefits in their diet.

    Statistics revealed that one in every five children suffer from asthma and respiratory conditions such as wheezing.

    The researchers have recommended that the study is conducted in other countries where consumption of fish oil is low.

    Dr. Christopher Ramsden said, “future work is also needed to determine whether lower doses are effective and whether these results can be replicated in other populations.” Dr. Ramsden added that “before these findings can be applied to clinical practice, it is, therefore, imperative to ensure that this dose had no adverse effects on behavior, cognition or other long-term outcomes.”

    Read more

    No tags.
    NextPrevious


    KONTAKT

    DBAC
    Dansk BørneAstma Center
    Herlev og Gentofte Hospital
    Telefon +45 3867 7360
    kontakt@dbac.dk
    DBAC • Herlev og Gentofte Hospital • Danmark © 2023
    • 20200227-P4-morgen-Rikke
    • Astma hos skolebørn
    • Astma hos små børn (Bisgaard)
    • COPSAC Acute (Antibiotika)
    • COPSAC informationsaften
    • COPSAC-Severe
    • Dansk BørneAstma Center
      • ABC-DK
      • Forebyggelse
      • Forskning
      • Forskningscentre
      • Generelt om allergi
      • Generelt om eksem
      • Input fra COPSAC familier
      • Knud har tabt pusten
      • Metoder
      • Nyheder
      • Om astma
        • Generel astma behandling
          • Astmabehandling småbørn
          • Behandling af astma hos større børn
        • Generelt om astma hos børn
          • Asthma hos små børn
          • Astma hos større børn
        • Gode råd
        • Undersøgelser
      • Om DBAC
        • Beliggenhed
        • Bestyrelsen
        • Fonde
        • Hjælp os med at hjælpe
        • Jobs
        • Kontakt
        • Litteratur til forældre
        • Patient- og lægeorganisationer
        • Persondatapolitik
        • Sponsorer
      • Spil
      • Undersøgelser
      • video
    • FAVORIT
    • Forebyggelse af astma hos børn (TEST-tilmelding)
    • Forebyggelse af astma hos børn (TEST)
    • Hans Bisgaard
    • Hans Bisgaard nekrolog
    • Indeklima og sundhed på Bellahøj
    • Lokale steroider for børn med astma
    • Mælkeallergi
    • myter og fakta om børneastma
    • Persondatapolitik
    DBAC